New Stock News | Bansun Pharmaceutical and other companies' Hong Kong IPOs have their materials accepted by the CSRC.
The China Securities Regulatory Commission released the "Filing Status Table for Overseas Securities Offering and Listing by Domestic Enterprises (Initial Public Offering and Full Circulation) (as of September 24, 2026)."
The China Securities Regulatory Commission (CSRC) has released the "Filing Status Table for Overseas Securities Offering and Listing by Domestic Enterprises (Initial Public Offering and Full Circulation)". Among them, the CSRC listing filing status for the Hong Kong IPOs of Bansun Pharmaceutical and other companies is "Accepted".
Related Articles
AK MEDICAL (01789) repurchased 50,000 shares on October 22 for approximately HK$214,200.
XUNFEIHEALTH (02506) Fully Completes Major Upgrade of Spark Medical Large Model Trained on Fully Domestic Computing Power; Spark Medical Large Model V3.7 Officially Released
CNBM (03323) completes issuance of RMB 3 billion corporate bonds
AK MEDICAL (01789) repurchased 50,000 shares on October 22 for approximately HK$214,200.
XUNFEIHEALTH (02506) Fully Completes Major Upgrade of Spark Medical Large Model Trained on Fully Domestic Computing Power; Spark Medical Large Model V3.7 Officially Released
CNBM (03323) completes issuance of RMB 3 billion corporate bonds
